Replies to post #21847 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

You can't have it all, as they say. -- Pyrr

However, as one former President often said: "We can do better."

Common phrases aside, if that cocktail therapy from TEVA makes it into production, it will be challenging for them to keep the cost below a couple hundred thousand dollars. I wish them well.

In Linda Power's London presentation, it appeared NWBO might be pivoting slightly away from Anti-PD1 and Car-T cocktails for safety reasons. In other words, ideally and ultimately the primary therapy (first line) would be DCVax-Direct, only enhanced with additional treatments if the response is inadequate.